Kennedy Capital Management Inc. cut its holdings in shares of Natus Medical Incorporated (NASDAQ:BABY) by 72.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 87,753 shares of the medical equipment provider’s stock after selling 228,500 shares during the quarter. Kennedy Capital Management Inc. owned about 0.27% of Natus Medical worth $3,273,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Eagle Asset Management Inc. increased its holdings in shares of Natus Medical by 0.3% during the 2nd quarter. Eagle Asset Management Inc. now owns 420,206 shares of the medical equipment provider’s stock worth $15,673,000 after acquiring an additional 1,268 shares during the last quarter. Principal Financial Group Inc. increased its holdings in shares of Natus Medical by 0.7% during the 2nd quarter. Principal Financial Group Inc. now owns 252,496 shares of the medical equipment provider’s stock worth $9,418,000 after acquiring an additional 1,879 shares during the last quarter. Mirador Capital Partners LP increased its holdings in shares of Natus Medical by 57.0% during the 2nd quarter. Mirador Capital Partners LP now owns 48,552 shares of the medical equipment provider’s stock worth $1,694,000 after acquiring an additional 17,618 shares during the last quarter. Prudential Financial Inc. increased its holdings in shares of Natus Medical by 162.0% during the 2nd quarter. Prudential Financial Inc. now owns 225,031 shares of the medical equipment provider’s stock worth $8,393,000 after acquiring an additional 139,130 shares during the last quarter. Finally, Bridge City Capital LLC acquired a new position in shares of Natus Medical during the 2nd quarter worth approximately $1,884,000. 92.65% of the stock is currently owned by institutional investors and hedge funds.

A number of research analysts have commented on the company. BidaskClub raised Natus Medical from a “sell” rating to a “hold” rating in a report on Saturday, July 1st. Zacks Investment Research raised Natus Medical from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $44.50.

Natus Medical Incorporated (NASDAQ:BABY) opened at 35.10 on Monday. The firm has a market capitalization of $1.14 billion, a price-to-earnings ratio of 60.83 and a beta of 0.96. Natus Medical Incorporated has a one year low of $31.65 and a one year high of $44.39. The firm has a 50-day moving average price of $33.95 and a 200-day moving average price of $36.10.

Natus Medical (NASDAQ:BABY) last issued its earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.01. The firm had revenue of $122.20 million for the quarter, compared to analyst estimates of $121.99 million. Natus Medical had a return on equity of 12.09% and a net margin of 4.20%. The business’s revenue was up 27.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.39 earnings per share. Analysts expect that Natus Medical Incorporated will post $1.70 EPS for the current year.

In other news, Director Robert A. Gunst sold 4,400 shares of Natus Medical stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $35.17, for a total value of $154,748.00. Following the completion of the transaction, the director now directly owns 50,850 shares in the company, valued at $1,788,394.50. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William M. Moore sold 3,000 shares of Natus Medical stock in a transaction on Monday, August 14th. The shares were sold at an average price of $34.10, for a total value of $102,300.00. Following the completion of the transaction, the director now owns 30,410 shares of the company’s stock, valued at $1,036,981. The disclosure for this sale can be found here. 5.50% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: This report was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/09/18/natus-medical-incorporated-baby-position-decreased-by-kennedy-capital-management-inc.html.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Want to see what other hedge funds are holding BABY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natus Medical Incorporated (NASDAQ:BABY).

Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Receive News & Stock Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related stocks with our FREE daily email newsletter.